ZWS (ZWS) Stock Analysis

Verdict: HOLD

High gross margins and clean balance sheet justify a premium, but weak 30-day price momentum and insider selling cap near-term upside.

Investment score: 58/100

Zurn Elkay boasts industry-leading gross margins (44.8%) and strong balance sheet health (D/E 0.33), but trades at a premium P/E of 27.9x vs peer median of 22.0x while suffering from technical momentum weakness (-12.3% in 30 days) and insider distribution.

Peers

PeerP/EP/BP/SEV/EBITDAROIC %Net margin %
LII16.349.702.3612.770.15
MAIR109.033.076.2432.480.05
WMS21.965.263.0512.320.14
OC-15.762.731.0523.15-0.07
MOD70.178.422.9534.740.04

View the full interactive analysis